Opioid use disorder in pregnancy
| Autor: | Kristin Harter |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
breastfeeding Breastfeeding Affect (psychology) methadone 03 medical and health sciences Psychopharmacology Pearls 0302 clinical medicine precipitated withdrawal medicine Pharmacology (medical) 030212 general & internal medicine Dosing General Pharmacology Toxicology and Pharmaceutics Intensive care medicine Pregnancy opioid use disorder (OUD) 030219 obstetrics & reproductive medicine business.industry labor and delivery pain Opioid use disorder buprenorphine medicine.disease Neuropsychology and Physiological Psychology neonatal abstinence syndrome (NAS) neonatal opioid withdrawal syndrome (NOWS) Neurology (clinical) Substance use medication-assisted treatment (MAT) business Buprenorphine medicine.drug Methadone |
| Zdroj: | The Mental Health Clinician |
| ISSN: | 2168-9709 |
| DOI: | 10.9740/mhc.2019.11.359 |
| Popis: | The number of pregnant people affected by the opioid epidemic in the United States continues to rise. The following key aspects of opioid use disorder in pregnancy are explored through the progression of a pregnancy via a patient case: treatment options, treatment decisions, substance use screening, dosing modifications, and other aspects of peripartum care. Many factors affect opioid use disorder treatment choices during pregnancy; however, when a pregnant person is medically eligible for a therapy and multiple options are available locally, the ultimate decision regarding treatment selection should be left up to the patient and strong support services provided. This approach to treatment results in optimal maternal and neonatal outcomes and long-term maternal engagement and retention in care. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|